MediWound Ltd.

Overview

Compare with FITLIFE BRANDS, INC., Bon Natural Life Ltd or Charlie's Holdings, Inc., or pick any stock.

• TickerMDWD on Nasdaq¹
• IndustryMedicinal Chemicals & Botanical Products¹
• HeadquartersL3¹
• Incorporated inIsrael³
• Business address42 Hayarkon Street, Yavne, L3 8122745³
• Filer categoryAccelerated filer³
• Legal formCorporation

See how the biggest companies compare on our leaderboards

Corporate structure

MediWound Ltd. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What MediWound Ltd. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Investments

Intangibles and goodwill

Inventory

Leadership

Who has led MediWound Ltd., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerOfer Gonen Mar 18, 2026 to now¹¹
• Chief financial officerKalfon Hana Luxenburg Mar 18, 2026 to now¹²
• Chief operating officerShmuel Hess Mar 18, 2026 to now¹³

Named in SEC Form D filings

People the company listed in its private-offering notices.

• Executive OfficerBoaz Gur-Lavie named Oct 4, 2022 to Oct 6, 2022²²
• Executive OfficerLior R. Rosenberg named Oct 4, 2022 to Oct 6, 2022²²
• Executive OfficerTzvi R. Palash named Oct 4, 2022 to Oct 6, 2022²²
• DirectorAssaf R. Segal named Oct 4, 2022 to Oct 6, 2022²²
• DirectorNissim R. Mashiach named Oct 4, 2022 to Oct 6, 2022²²
• DirectorSharon R. Kochan named Oct 4, 2022 to Oct 6, 2022²²
• DirectorSharon R. Malka named Oct 4, 2022 to Oct 6, 2022²²

Timeline

1. Mar 18, 2026New chief executive Ofer Gonen becomes CEO¹¹

Calendar

Coming up

1. Nov 19, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($0.24) a share, on Nov 20, 2025.²³

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

191 filings to the SEC since October 2021: 5 annual reports, 16 insider forms, 36 large holders, 2 private raises, 132 other. The latest 20:

1. Sep 2, 20264 EDGAR
2. Aug 28, 2026SCHEDULE 13G/A EDGAR
3. Aug 28, 2026144 EDGAR
4. Aug 28, 20264 EDGAR
5. Aug 14, 2026SCHEDULE 13G/A EDGAR
6. Aug 13, 20266-K EDGAR
7. Jun 4, 20264 EDGAR
8. Jun 2, 20264 EDGAR
9. Jun 1, 20264 EDGAR
10. May 27, 20266-K EDGAR
11. May 15, 2026SCHEDULE 13G EDGAR
12. May 6, 20266-K EDGAR
13. Apr 2, 20266-K EDGAR
14. Mar 30, 20266-K EDGAR
15. Mar 25, 20263 EDGAR
16. Mar 18, 20263 EDGAR
17. Mar 18, 20263 EDGAR
18. Mar 18, 20263 EDGAR
19. Mar 18, 20263 EDGAR
20. Mar 18, 20263 EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

7 open-market trades by officers, directors and large owners since October 2021: 4 buys and 3 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Alapkezelo Zrt. HoldSCHEDULE 13G/A, 3 filings Sep 19, 2025 to Aug 28, 2026²⁴
• PRICE T ROWE ASSOCIATES INC /MD/SCHEDULE 13G/A, 4 filings Nov 14, 2025 to Aug 14, 2026²⁵
• Rosalind Advisors, Inc.SCHEDULE 13G/A, 10 filings Dec 21, 2022 to Feb 11, 2026²⁶
• Yelin Lapidot Holdings Management Ltd.SCHEDULE 13G/A, 2 filings Oct 1, 2024 to Feb 5, 2026²⁷
• ACCESS INDUSTRIES, LLCSCHEDULE 13D/A, 1 filing Oct 3, 2025²⁸
• Point72 Asset Management, L.P.SC 13G/A, 2 filings Feb 8, 2023 to Nov 14, 2024²⁹
• Access Industries Holdings LLCSC 13D/A, 6 filings Mar 17, 2022 to Jul 19, 2024³⁰
• Molnlycke Health Care ABSC 13D, 1 filing Jul 19, 2024³¹
• Deep Insight Limited PartnershipSC 13G/A, 2 filings Dec 5, 2022 to Jan 8, 2024³²
• Israel Biotech Fund II, L.P.SC 13G/A, 2 filings Dec 5, 2022 to Jan 8, 2024³³
• Lior RosenbergSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 2023³⁴
• Migdal Insurance & Financial Holdings Ltd.SC 13G, 1 filing Feb 2, 2022³⁵

Money raised

Private offerings the company reported to the SEC on Form D.

1. Sep 22, 2022Raised $13.3 million in a private offering of equity Form D: 13 investors so far Form D
2. Sep 22, 2022Raised $17.2 million in a private offering of securities Form D: 10 investors so far Form D

SEC filer profile

How MediWound Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARMediWound Ltd.¹
• CIK0001593984
• Filer statusAccelerated filer not an emerging growth company; not a shell company³⁶
• Incorporated inIllinois³⁶
• Fiscal year endsDecember 31¹
• Industry code (SIC)2833 Medicinal Chemicals & Botanical Products¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business address42 Hayarkon Street, Yavne, L3 8122745¹
• Phone972779714100¹
• Shares outstanding12,835,148 shares as of Dec 31, 2025³⁶
• AuditorSomekh Chaikin, Tel Aviv, Israel PCAOB ID 1057; it also attests to the company’s internal control over financial reporting³⁶
• On EDGAR sinceDec 23, 2013¹
• Filings393 in all: 6-K (205), SC 13G/A (32), SC 13G (20), 20-F (12), CORRESP (12), 3 (11), 424B3 (10), S-8 (10)¹
  All 31 form types

  SCHEDULE 13G/A (10), UPLOAD (9), EFFECT (8), 424B5 (7), 4 (5), CT ORDER (5), F-3 (5), SC 13D/A (5), 6-K/A (3), DRS/A (3), F-1/A (3), SCHEDULE 13G (3), 144 (2), D (2), F-1 (2), SC 13D (2), 424B4 (1), 8-A12B (1), CERTNAS (1), DRS (1), POS AM (1), POS EX (1), SCHEDULE 13D/A (1)

• Latest filingsAnnual report (20-F) Mar 5, 2026

Securities registered for trading

From the cover page of the 20-F filed Mar 5, 2026 (Section 12(b) of the Exchange Act).³⁶